Prabhavathi Fernandes - May 25, 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Director
Signature
/s/ Prabhavathi Fernandes by Sanjay Subramanian, her attorney-in-fact
Stock symbol
OCGN
Transactions as of
May 25, 2021
Transactions value $
-$243,675
Form type
4
Date filed
5/27/2021, 04:07 PM
Next filing
Jun 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Options Exercise $5.46K +19.5K $0.28 19.5K May 25, 2021 Direct
transaction OCGN Common Stock Sale -$160K -19.5K -100% $8.21 0 May 25, 2021 Direct F1
transaction OCGN Common Stock Options Exercise $25.6K +14K $1.83 14K May 25, 2021 Direct
transaction OCGN Commom Stock Sale -$115K -14K -100% $8.19 0 May 25, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Options Exercise $0 -19.5K -36.11% $0.00 34.5K May 25, 2021 Common Stock 19.5K $0.28 Direct F3
transaction OCGN Option (Right to Buy) Options Exercise $0 -14K -11.11% $0.00 112K May 25, 2021 Common Stock 14K $1.83 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.19 to $8.23. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.18 to $8.20. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The option, initially representing a right to purchase a total of 54,000 shares, vests mothly in equal installments over three years commencing on May 5, 2020, subject to continued service with the Company through the applicable vesting dates.
F4 The option, initially representing a right to purchase a total of 126,000 shares, vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company through the applicable vesting dates.